Hyperfine (HYPR) EBITDA Margin Growth (3y) (2024 - 2026)
Hyperfine (HYPR) EBITDA Margin Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | -201.00 |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 586.00 |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 736.00 |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 887.00 |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 963.00 |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 212.00 |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 535.00 |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 244.00 |
| 10 | Hyperfine | 90.47 Mn | 45.70 Mn | 1.98 Mn | 12,888.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12,888.00 |
| Mar 31, 2026 | 27,542.00 |
| Dec 31, 2025 | 81,222.00 |
| Sep 30, 2025 | 30,614.00 |
| Jun 30, 2025 | 115,695.00 |
| Mar 31, 2025 | 106,513.00 |
| Dec 31, 2024 | 551,945.00 |
| Sep 30, 2024 | 411,686.00 |
| Jun 30, 2024 | 377,560.00 |
| Mar 31, 2024 | 203,479.00 |